News
· 4hPfizer beats in Q2 earnings, reaffirms 2025 outlook
Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 billion in revenues. The company reported revenues of $14.7 billion, compared to Wall Street expectations of $13.5 billion, and earnings per share of $0.78, versus estimates of $0.58 per share.
This would indicate a 6% year-over-year growth in earnings and a 3% increase in sales when compared to the previous year’s ...
Joby Aviation Inc (NYSE:JOBY) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for Q2 2025 ...
U.S. commercial revenue skyrocketed 93% year over year on phenomenal demand for the company's artificial intelligence ...
Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for ...
WinRevair’s Phase 3 HYPERION trial was stopped early for efficacy, with positive top-line results announced in the month ...
Palantir recently secured a major victory with the U.S. Army's new Enterprise Agreement that establishes a comprehensive ...
Q2 2025 Management View Paul Richards, EVP and CFO, reported "For the second quarter, we reported a net income of $0.54 per ...
The best place to start is to determine how the stock is valued, and one of the most popular and effective metrics to help make that judgment is earnings per share, known as EPS. "We use a wide ...
Nifty 50 EPS projected to grow by 10% in FY26, supported by fiscal measures and sectoral preferences, per Motilal Oswal.
Meanwhile, Trump continued to amp up pressure on trade Monday, threatening to hike tariffs on India. Separately, in a Tuesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback